Production capacity increase with high objectives
Astellas Ireland Company Ltd. (formed in 2005 following the merger of Yamanouchi Ireland & Fujisawa Ireland) is part of the Astellas Pharma Inc. which has ist headquarters in Toyko. In order to meet increased productivity requirements for the immunosuppressive drug Prograf (used in transplants), Astellas needed additional equipment to their existing Bosch lines. These lines process Prograf and incorporate extensive measures to protect operating personnel. When placing the order for the new equipment Astellas was therefore interested in a solution, which increased productivity while minimizing technical and processing expenditure for operator protection. To meet those and other objectives Bosch developed a complete solution consisting of a capsule filling, machine plus appropriate peripherals...
(PDF, 186KB)
For more information please contact:
Felix Nink
Phone: +49 711 811 57 526
felix.nink@boschpackaging.com